Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation
Eileen C. Goodwin(University of Pennsylvania), Laura M. Walker(Children's Hospital of Philadelphia), Syed M. Moin(National Institutes of Health), Joan O. Ngwuta(National Institute of Allergy and Infectious Diseases), Ruth I. Connor(Dartmouth–Hitchcock Medical Center), Barney S. Graham(National Institutes of Health), Patricia Bai(Dartmouth College), Daniel Wrapp(Duke University), Arvind Sivasubramanian(Adimab (United States)), Morgan S. A. Gilman(Harvard University), Peter F. Wright(Dartmouth College), Man Chen(Shandong Provincial Hospital), Jason S. McLellan(The University of Texas at Austin)
Cited by 166
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|Science|2020|1.4k